Navigation Links
Vaccine Ninety Percent Effective Against Cervical Cancer

A new vaccine protects nine out of ten women against cervical cancer linked to two strains of the deadly human papillomavirus (HPV), according to a study published Thursday.

HPV types 16 and 18 account for 70 percent of cervical cancer cases worldwide, which number about 500,000 per year, according to the UN Population Fund (UNFPA).

If left untreated, invasive cervical cancer is almost always fatal.

In a clinical trial, more than 9,000 women were vaccinated with the experimental drug, with a control group receiving a vaccine for hepatitis A.

Over a 15-month follow up period, the drug showed a 90.4 percent efficacy against the kind of pre-cancerous lesions that are a precursor to full-blown cervical cancer.

"The vaccine is effective, well-tolerated and immunogenic" -- meaning it produces an immune response -- "in a broad population of young adult women," said University of Helsinki professor Jorma Paavonen, who led the study.

Side-effects were minimal, the study found.

The drug being tested, which has yet to go to market, would be sold under the brand name Cervarix, and is manufactured by British firm GlaxoSmithKline, which funded the study.

A similar drug produced by US firm Merck, Gardasil, also vaccinates against HPV types 16 and 18, and has already been approved for sale in many countries.

More than half of the women vaccinated in the phase III trials were from Finland, with the rest coming from 13 other countries, including many in the developing world, where 90 percent of new cases occur.

"The vaccine is not therapeutic but prophylactic," Paavonen said by telephone, explaining that it would not benefit women who already test positive for both of the targeting virus strains.

But those who were exposed to only one of the strains would be protected from the other, and even those who had been exposed to both "rec
'"/>




Page: 1 2

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
Breaking Medicine News(10 mins):Health News:REES Announces New Baltimore Office 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11